Our top pick for
Beginners

Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Creative Medical Technology Holdings Inc is a biotechnology business based in the US. Creative Medical Technology Holdings shares (CELZ) are listed on the NASDAQ and all prices are listed in US Dollars. Creative Medical Technology Holdings employs 4 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
Latest market close | $0.64 |
---|---|
52-week range | $0.59 - $20.00 |
50-day moving average | $1.21 |
200-day moving average | $3.23 |
Wall St. target price | $10.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.95 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.6371 from 2022-07-06
1 week (2022-06-30) | -15.05% |
---|---|
1 month (2022-06-07) | -27.98% |
3 months (2022-04-07) | -82.05% |
6 months (2022-01-07) | -80.15% |
1 year (2021-07-07) | 1,948.55% |
---|---|
2 years (2020-07-07) | 14,379.55% |
3 years (2019-07-05) | 17,118.92% |
5 years (2017-07-07) | 70.80% |
Revenue TTM | $102,754 |
---|---|
Gross profit TTM | $39,805 |
Return on assets TTM | -46.87% |
Return on equity TTM | -282.98% |
Profit margin | 0% |
Book value | $1.44 |
Market capitalisation | $7.1 million |
TTM: trailing 12 months
We're not expecting Creative Medical Technology Holdings to pay a dividend over the next 12 months.
You may also wish to consider:
Creative Medical Technology Holdings's shares were split on a 1:500 basis on 9 November 2021. So if you had owned 500 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Creative Medical Technology Holdings shares – just the quantity. However, indirectly, the new 49900% higher share price could have impacted the market appetite for Creative Medical Technology Holdings shares which in turn could have impacted Creative Medical Technology Holdings's share price.
Over the last 12 months, Creative Medical Technology Holdings's shares have ranged in value from as little as $0.591 up to $20. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Creative Medical Technology Holdings's is 5.1189. This would suggest that Creative Medical Technology Holdings's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Creative Medical Technology Holdings's beta into context you can compare it against those of similar companies.
Creative Medical Technology Holdings, Inc. , a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.